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Herpes simplex virus type-1 (HSV-1) and HSV-2 are double-
stranded DNA viruses of the family Herpesviridae that infect mucosal
surfaces, usually via epithelial tissue that has been damaged by
abrasion or trauma (Cunningham et al., 2006). HSV-1 infection is
accompanied by virus replication and destruction of epithelial cells,
producing a primary lesion at the initial site of infection before
establishment of latent infection in sensory neurons. Periodic
reactivation results in shedding of virus at epithelial surfaces in the
presence or absence of clinical symptoms.
HSV-1 pathogenesis has been investigated in vivo using several
different routes of infection, including ocular, vaginal, footpad,
intranasal, peritoneal and ﬂank epidermal inoculation of mice (Hill
et al., 1975; Hurd and Robinson, 1977; Reading et al., 2006; Simmons
and Nash, 1984; Sydiskis and Schultz, 1965; Tullo et al., 1982; Walz
et al., 1977). In the epidermal model, the ﬂank is scariﬁed or abraded
in the presence of HSV-1 and 2–3 days later, a primary lesion forms at
the site of inoculation. Within 4–7 days, secondary lesions form at
sites distant from the inoculation site resulting from retrogradetransport of virus from the inoculation site to the associated ganglion
and subsequent anterograde transport to secondary sites in the
epidermis (Simmons and Nash, 1984; Sydiskis and Schultz, 1965; van
Lint et al., 2004). Thus, the timing and histopathology of disease in the
murine ﬂank model effectively mimics HSV-1 infection in humans
(Simmons and Nash, 1984; Sydiskis and Schultz, 1965).
Protective immunity to HSV-1 requires a coordinated response by
both innate and adaptive immune systems. During the early phase of
HSV-1 infection, the antiviral activities of macrophages (Bauer et al.,
2000; Sarmiento, 1988) and natural killer (NK cells) (Adler et al.,
1999; Habu et al., 1984; Reading et al., 2006) have been implicated in
limiting early virus replication and spread. Neutrophils are the ﬁrst
and predominant cell type observed in lesions associated with the
development of herpetic stromal keratitis (Chen et al., 1996; Stumpf
et al., 2002; Thomas et al., 1997) and in the brain after intranasal
infection with neurovirulent HSV-1 (Marques et al., 2008). Following
cutaneous footpad infection with HSV-1, neutrophils localized to both
dermal and epidermal layers of the skin (Watanabe et al., 1999) and
showed a similar distribution in the dermis and epidermis of human
herpetic lesions (Patel et al., 2009).
Despite their prominence in HSV-1-induced lesions, the precise role
neutrophils play in host defense and/or development of inﬂammatory
lesions has not been clearly deﬁned. Several studies have attempted to
identify neutrophils in HSV-1-infected tissues using mAb RB6-8C5
(Bauer et al., 2007; Divito and Hendricks, 2008; Stumpf et al., 2002;
Thomas et al., 1997; Yan et al., 1998), a mAb originally deﬁned by its
ability to bind to granulocyte receptor-1 (Gr-1) (Fleming et al., 1993).
Moreover, antibody-mediated depletion of neutrophils with mAb RB6-
Fig. 1. Clinical disease and virus replication following ﬂank infection of B6 mice with
HSV-1. Groups of 5 mice were infected with 106 PFU of HSV-1 by ﬂank scariﬁcation.
(A) At the time-points indicated, skin samples (corresponding to the primary (black
circles) and secondary (white squares) sites) and DRG (black triangles) were removed
and titres of infectious virus were determined in clariﬁed homogenates by plaque assay.
Data represent mean virus titres±1 SD. The detection limit for the assay (0.6 Log10
PFU/sample) is indicated by the dotted line. (B) Lesion severity. Lesion severity was
determined on following ﬂank infection using the scoring system described inMaterials
and methods. Lesion scores from individual mice are shown are as circles and
horizontal bars represent the mean lesion scores. Data are representative of 3
independent experiments.
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(Thomas et al., 1997; Tumpey et al., 1996) or intravaginal models
(Milligan, 1999) of HSV-1 and HSV-2, respectively. In addition to the
Ly6G antigen expressed at high levels by neutrophils, mAb RB6-8C5
binds to Ly6C which is expressed by a range of other leukocyte
populations, including plasmacytoid dendritic cells (DC) (Nakano et al.,
2001),monocytes (Geissmann et al., 2003) and CD8+ T cells (Matsuzaki
et al., 2003; Tumpey et al., 1996). While clear differences exist in
the nature of the inﬂammatory responses elicited to HSV-1/HSV-2 at
different sites of infection, studies using mAb RB6-8C5 to deplete
Ly6Ghigh neutrophils in each of these murine models are likely to be
complicated by the unwanted depletion of additional Ly6C+ leukocyte
subsets.
Recent studies have used Ly6G-speciﬁc mAb 1A8 to induce
systemic depletion of Ly6Ghigh neutrophils, but not Gr-1high blood
monocytes (Daley et al., 2008) and antibody-mediated depletion of
Ly6G+ cells during inﬂuenza infection was associated with enhanced
virus replication, pulmonary inﬂammation and death (Tate et al.,
2009). Few neutrophils were recruited to the airways following
intranasal infection with HSV-1 and treatment of mice withmAb RB6-
8C5, but not mAb 1A8, was associated with exacerbated virus
replication and disease (Wojtasiak et al.). Herein, we have used
mAb 1A8 to identify and enumerate neutrophils in skin lesions and
dorsal root ganglia (DRG) from C57BL/6 (B6) mice at various times
after ﬂank scariﬁcation with HSV-1. Moreover, we demonstrate that
treatment of mice with either mAb 1A8 or mAb RB6-8C5 induced
systemic neutropenia, however only depletion of Gr-1+ cells was
associated with increased virus replication and enhanced lesion
severity in the zosteriform model. Together, these ﬁndings suggest
that neutrophils do not play a major role in controlling HSV-1
infection in the skin. Furthermore, they further highlight the problems
associated with the widespread use of antibody-mediated depletion
of Gr-1+ cells to deﬁne the role of neutrophils in vivo.
Results
Flank infection of C57BL/6 mice with HSV-1
HSV-1 typically initiates infection of mucosal membranes or skin,
where the virus replicates in epithelial cells before establishing a
latent infection in the associated sensory ganglia. In order to
investigate the role of neutrophils during HSV-1 infection, we ﬁrst
characterized the parameters of disease that could be quantiﬁed
following ﬂank zosteriform infection of B6 mice with HSV-1.
Epidermal abrasion and subsequent zosteriform lesion development
in mice is an established model for the development of recrudescent
lesions in humans (Simmons et al., 1992). During zosteriform disease,
virus spreads from the primary inoculation site in the skin to sensory
dorsal root ganglia (DRG) and subsequently reappears in the distal
ﬂank. This progression is seen in Fig. 1A, where inoculation of 106 PFU
onto abraded skin of the ﬂank (primary site) was associated with
subsequent detection of infectious virus in DRG and skin (secondary
site) after day 3 post-infection and mice developed an erythematous
skin lesion that was graded daily over an 11 day observation period
(Fig. 1B). No paralysis or death was observed over a 30-day monitoring
period.
Recruitment of neutrophils to skin following intranasal or ﬂank infection
with HSV-1
We next assessed the cellular inﬂammatory response following
ﬂank infection of mice with 106 PFU of HSV-1, with a particular focus
on characterizing the neutrophil response to infection. Based on
previous ﬁndings (Daley et al., 2008), we have utilized mAb 1A8,
speciﬁc for Ly6G, to identify neutrophils from naïve and HSV-1-
infected mice. We have used mAb 1A8 to identify a distinctivepopulation of Ly6Ghigh cells in the blood of uninfected mice and in the
skin from HSV-1-infected mice (Fig. 2A) and cell sorting demonstrat-
ed that N95% of Ly6Ghigh blood leukocytes displayed the characteristic
nuclear morphology of neutrophils when examined using light
microscopy (data not shown).
Previous studies utilizing immunohistochemical staining with
mAb RB6-8C5 have demonstrated neutrophil recruitment and
accumulation in murine skin following inoculation of HSV-2 onto
the abraded skin of the footpad (Watanabe et al., 1999). In the current
study, collagenase/DNase treatment was used to prepare single cell
suspensions of skin samples from HSV-1-infected mice and these
were analyzed by ﬂow cytometry for expression of CD45 and Ly6G.
Fig. 2B demonstrates the accumulation of CD45+ cells in the skin
following ﬂank infection of HSV-1, with neutrophils comprising 18±
6.5, 34±7.2, 35±6.4 and 9.0±10.5% of CD45+ leukocytes at days 3,
5, 7 and 10, respectively. Total leukocyte numbers recovered from the
skin of uninfected mice were very low (9.7×103±1.8×103 cells/
mouse) and neutrophils comprised 6.5±0.5% of these cells. In
contrast to results obtained in the skin, neutrophils comprised b5%
of leukocytes inﬁltrating the DRG 3, 5, 7 and 10 days after ﬂank
infection with HSV-1 in 2 independent experiments.
Compared to skin from naïve animals, enhanced levels of the
neutrophil chemoattractants KC and MIP-2 (Fig. 2C) were detected in
homogenates of skin from HSV-1-infected mice at day 3 and day 7
post-infection, consistent with the timing of neutrophil inﬁltration.
Compared to day 3 post-infection, levels of both KC and MIP-2 were
signiﬁcantly reduced at day 7, in agreement with our ﬁndings that
neutrophil numbers hadwaned in skin lesions after this time (Fig. 2B).
It should be noted that levels of MIP-2/KC in the skin of mice that
Fig. 2. Neutrophil recruitment following HSV-1 infection. Groups of 5 mice were
infected with 106 PFU of HSV-1 by ﬂank scariﬁcation and at the times indicated, mice
were euthanised and cell suspensions prepared. (A) Representative dot plots showing
Ly6G expression on CD45+ leukocytes recovered from (i) the blood of naïve mice (ii)
skin 3 days after ﬂank scariﬁcation. The gate used to identify Ly6Ghigh neutrophils for
subsequent analysis is shown. (B) At various times after ﬂank infection, ﬂow cytometry
was used to determine numbers of CD45+ leukocytes (white bars) and CD45+ Ly6Ghigh
neutrophils (black bars) in skin and DRG. Data show the mean cell number ± 1 SD from
groups of 4–5 mice and are representative of two or more independent experiments.
(C) Levels of neutrophil-attracting chemokines in skin homogenates from uninfected
(UN) or HSV-1-infected mice at days 3 and 7 post infection. Levels of MIP-2 and KC in
clariﬁed skin homogenates were determined by ELISA. Results are expressed as pg/mg
of tissue and bars represent the mean concentration of each chemokine±1 SD. The
detection limit for each mediator is indicated by a dotted line. *=levels of chemokine
that were signiﬁcantly greater than levels detected in skin from uninfected animals
(pb0.05, one-way ANOVA).
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different to those from mice that were clipped and depilated at either
3 or 7 days post-treatment (data not shown), indicating that abrasion
alone did not induce high levels of neutrophil chemoattractants in
response to abrasion injury.Selective expression of Ly6G by murine neutrophils from naïve or
HSV-1-infected mice
mAb RB6-8C5 (anti-Gr-1) has been used extensively to detect and
deplete neutrophils from mice (reviewed by (Egan et al., 2008)),
however in addition to Ly6Ghigh neutrophils, thismAb cross-reactswiththe Ly6Callele expressed bypDC, subsets ofmonocytes and CD8+T cells
(Geissmann et al., 2003; Matsuzaki et al., 2003; Nakano et al., 2001).
Thus, mAb 1A8, which is speciﬁc for Ly6G, may offer signiﬁcant
advantages over mAb RB6-8C5 for both identiﬁcation and depletion of
neutrophils in murine models of infection and inﬂammation.
We therefore compared the ability of mAb 1A8 and mAb RB6-8C5
to bind to speciﬁc leukocyte subsets in splenocyte suspensions
prepared from naïve or HSV-1-infected mice. mAb RB6-8C5 bound
strongly to pDC and CD8+ splenocytes, and to a lesser extent to NK
cells, macrophage-like cells and cDC from naïve mice (Fig. 3A). Of
interest, Gr-1 expression was upregulated on CD8+ T cells, macro-
phage-like cells and cDC leukocyte populations in the spleen 7 days
after ﬂank infection ofmicewith HSV-1 (Fig. 3B). In contrast, mAb 1A8
did not bind signiﬁcantly to any of the additional leukcoyte
populations examined on splenocytes recovered from naïve
(Fig. 3A) or HSV-1 infected mice (Fig. 3B).
Based on the ﬁndings described above, treatment of mice with
mAb RB6-8C5 is likely to deplete neutrophils and additional leukocyte
populations, including sub-populations of CD8+ T cells, thereby
complicating the interpretation of studies during the latter phase of
infection. The HSV-1-speciﬁc CD8+ T cell response in C57BL/6 mice is
largely directed towards the immunodominant SSIEFARL epitope in
the gB glycoprotein of the virus (Wallace et al., 1999). As seen in
Fig. 3C, gB-speciﬁc CD8+ T cells present in spleen and skin at day 7
post-infection (upper panels) were shown to bind mAb RB6-8C5 but
not mAb 1A8 (lower panels).
Depletion of Gr-1+ cells, but not Ly6C+ cells, leads to enhanced virus
replication, cytokine production and lesion severity in the zosteriform
model of HSV-1 infection
Neutrophils comprise a signiﬁcant proportion of cells inﬁltrating
the skin of HSV-1-infected mice (Fig. 2B), therefore it was of interest
to determine their role in the zosteriform infection model. Despite
profound (N95%) depletion of neutrophils in the blood, we did not
observe signiﬁcant enhancement in virus titres in the skin or DRG of
1A8-treated mice at any time-point tested (Fig. 4A). Treatment of
mice withmAb RB6-8C5 also depleted N90% of circulating neutrophils
(IgG-treated controls=6.9×105±4×104 compared to RB6-treated
animals=3.2×104±1×104 neutrophils/ml blood), and was associ-
ated with enhanced virus replication in skin 7 days after ﬂank
infection (Fig. 4B), although titres in DRG were not signiﬁcantly
different to IgG- or 1A8-treated animals (data not shown). In 2
independent experiments, infectious virus was not detected in skin or
DRG of IgG-, 1A8- or RB6-8C5-treated mice 10 days post-infection
(data not shown), indicating no major delay in clearance of lytic virus
in mice depleted of Gr-1+ cells. Infectious virus was not detected in
the brain of any of the treated groups at the time-points examined.
We next graded the severity of zosteriform lesions of HSV-1-
infected mice treated with IgG, 1A8 or RB6. Depletion of Ly6G+ cells
with mAb 1A8 did not visibly affect lesion development or resolution
(Fig. 4C), however depletion of Gr-1+ cells was associated with a
marked increase in lesion severity. Despite the absence of infectious
virus in skin samples taken from RB6-8C5-treated animals at day 10
post-infection, onlymice depleted of Gr-1+ cells developed ulceration
in adjacent dermatomes and/or contralateral skin vesicles 7–11 days
after infection.
Neutrophils were a prominent component of inﬂammatory cells
inﬁltrating the zosteriform lesions (Fig. 2A), yet treatment of mice
with mAb 1A8 did not exacerbate virus replication (Fig. 4A) or lesion
severity (Fig. 5C). Although profound depletion of neutrophils (N95%)
was observed in the blood of mice treated with mAb 1A8, it was
important to determine neutrophil numbers in the actual zosteriform
skin lesions. Mice infected with HSV-1 by ﬂank scariﬁcation were
treated with mAb 1A8, mAb RB6-8C5 or control IgG and euthanized at
day 7 post-infection. Skin cell suspensions were prepared and CD45+
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Fig. 5. Cellularity of skin cell suspensions from IgG-, 1A8- or RB6-8C5-treated mice
7 days after ﬂank infection with 106 PFU of HSV-1. Groups of 5 mice treated with either
IgG, 1A8 or RB6-8C5 (at days −1, +1, +3 and +5, as described in Materials and
Methods) were infected at day 0 and single cell suspensions were prepared from
excised skin samples at day 7 post-infection. Shown are the mean numbers (± SD) of
(A) total leukocytes (CD45+), DC (CD11c+ MHC IIhigh) and macrophage-like cells (F4/
80+), as well as (B) total T cells (TCRβ+), CD4+ T cells (CD4+, TCRβ+), CD8+ T cells
(TCRβ+), B220+ cells and NK cells (NK1.1+ , TCRβ+), recovered from the skin of IgG-,
1A8- or RB6-8C5-treated mice (n=4–5 mice/group). Data were analyzed by one-way
ANOVA and no signiﬁcant differences (pN0.05) were reported between different
groups. Data shown are from 4 to 5 mice per group and are representative of at least 2
independent experiments.
Fig. 4. Treatment with mAb RB6-8C5, but not with mAb 1A8, during ﬂank infection of
mice with HSV-1 is associated with increased virus replication and lesion severity.
Groups of 5 B6 mice were depleted of neutrophils via i.p. administration of puriﬁed
mAb 1A8 (‘1A8’) or mAb RB6-8C5 (‘RB6’) 24 h prior to infection and every second
day thereafter. Control groups received an equivalent concentration of rat IgG (‘IgG’).
(A)Mice treatedwithmAb 1A8 (black bars) or control IgG (white bars)were euthanized
at various time points following infection and virus titres in clariﬁed homogenates of
skin and DRG were determined. (B) Mice were euthanized 7 days following infection
and treated with mAb 1A8, mAb RB6-8C5 or with control IgG and virus titres in clariﬁed
homogenates of skin and DRG were determined. Data shown in A and B represent the
mean virus titre ± 1 SD. Viral titres from mice treated with anti-Gr-1 antibodies were
signiﬁcantly greater than those from Ly6G-treated or IgG-treated mice **pb0.01, one
way ANOVA followed by Tukey's multiple comparison test. (C) Mice treated with mAb
1A8 (squares), mAb RB6-8C5 (triangles) or with control IgG (circles) were examined
after ﬂank infection with HSV-1 and lesion severity was scored as described inMaterials
and methods. Data show the mean lesion severity±1 SEM for groups of 4–5 mice.
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counts. Compared to IgG-treated controls, treatment with either mAb
1A8 ormAb RB6-8C5 led to amarked reduction in neutrophil numbers
recovered from the skin of HSV-1-infected mice (Expt. 1: IgG=
5.35×105 versus 1A8=1.47×105, RB6=1.20×105 neutrophils,
corresponding to 72.5% and 77.5% reductions in neutrophil numbers
in skin, respectively. Exp. 2: IgG=1.0×106 versus 1A8=1.03×105,
RB6=9.79×104 neutrophils corresponding to 73.9% and 75.2%
reductions in neutrophil numbers in skin, respectively. n=3 mice/
group and animals in each group were pooled for analysis). Moreover,
despite major differences in virus titres and lesion severity in the skin,
no major differences were noted in the effectiveness of mAb 1A8 or
mAb RB6-8C5 in depleting neutrophils from this site. Together, these
studies demonstrate that selective depletion of neutrophils with mAb
1A8 does not exacerbate virus replication or lesion severity during
HSV-1 zosteriform infection.Fig. 3. Expression of Gr-1 and Ly6G subsets on leukocytes from the spleen of naïve and HSV
7 days after ﬂank scariﬁcation with 106 PFU of HSV-1 strain KOS. Binding of ﬂuorescent-l
leukocytes prepared from (A) naïve animals or (B) HSV-1-infected mice are shown as grey
binding ofmAbs to pooled cell suspensions prepared from3 to 5mice/group. Leukocyte subse
cells, NK1.1+ (CD3-, NK1.1+) cells, macrophage-like, (Mϕ, F4/80+), conventional DCs (cDC, C
of ﬂuorescent-labelled mAb RB6-8C5 (′Gr-1′) and mAb 1A8 (‘Ly6G’) to gB-speciﬁc CD8+
Representative dot plots showing tetramer staining of gB-speciﬁc CD8+T cells are shown in th
histograms (lower panels) and isotype controls are shown as white histograms. A gate was se
for expression of Gr-1 or Ly6G are shown relative to this in each panel.Analysis of cell types and inﬂammatory mediators in zosteriform lesions
from HSV-1-infected mice treated with IgG, 1A8 or RB6-8C5
Given the marked enhancement in virus replication (Fig. 4B) and
lesion severity (Fig. 4C) observed in HSV-1-infected mice treated with
mAb RB6-8C5 compared to mice treated with mAb 1A8, we next
examined the cell types and inﬂammatory mediators present in
lesions from HSV-1-infected animals at day 7 post-infection. To
examine the leukocytes present in zosteriform lesions, skin cell
suspensions were prepared and stained for different leukocyte
subsets (Fig. 5). In general, there was a tendency to recover more
CD45+ cells from the skin of RB6-treated mice compared to IgG- or
1A8-treated animals, however this was not signiﬁcant in independent
experiments. Moreover, numbers of DC, macrophage-like cells (Fig. 5,
upper panels), T cells, B220+ cells or NK cells (Fig. 5, lower panels)
were not signiﬁcantly different between IgG-, 1A8- or RB6-treated
groups (pN0.05, one-way ANOVA). Of interest, we did observe sig-
niﬁcant reductions in the percentage of CD8+ T cells (IgG=3.4±0.4%,
1A8=3.1%±0.6, RB6=1.2±0.4%* of CD45+ cells; *pN0.05, one-
way ANOVA), DC (IgG=22.0±4.1%, 1A8=24.1±5.5%, RB6=11.1±
4.6%* of CD45+ cells; *pN0.05, one-way ANOVA) and macrophage-
like cells (IgG=35.3±6.9%, 1A8=36.6±5.7%, RB6=23.9±4.8%* of
CD45+ cells; *pN0.05, one-way ANOVA) in RB6-treated mice-1-infected mice. Splenocyte suspensions were prepared from naïve mice or from mice
abelled anti-Gr-1 (mAb RB6-8C5: Ly6G & Ly6C) and anti-Ly6G (mAb 1A8) to splenic
histograms. Appropriate isotype controls are shown as white histograms. Data show
tswere identiﬁed as follows: CD8+ cells (CD3+, CD8+), CD4+ cells (CD3+, CD4+), B220+
D11chigh, MHC Class IIhigh) and plasmacytoid DCs (pDC, PDCA-1+, CD11cint). (C) Binding
T cells was determined from spleen and skin of mice 7 days after ﬂank scariﬁcation.
e upper panels. Expression of Gr-1 and Ly6Gof gB-speciﬁc CD8+T cells are shown as grey
t to include 5% of cells in the isotype control and the percentages of cell staining positive
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translate into signiﬁcant differences in cell numbers.
Next, we determined levels of inﬂammatory mediators in the skin
of HSV-1-infected mice. Compared to naïve animals, infection of IgG-,
1A8- or RB6-8C5-treated mice was associated with increased levels of
IFN-γ and TNF-α (Fig. 5) in skin homogenates at day 7 post-infection
whereas levels of IL-12p70, IL-10 and IL-6 were generally below
detection (data not shown). Of interest, MCP-1 levels were low in the
skin of naive animals and HSV-1-infected animals treated with IgG or
1A8, but were profoundly enhanced in homogenates prepared from
RB6-8C5 treated mice infected with HSV-1 (Fig. 5).
Discussion
Following epidermal abrasion and infection with HSV-1, virus
localizes to keratinocytes in the epithelial layers of the skin, dendritic
cells in the underlying dermis and peripheral nerve ﬁbres at the
dermal-epidermal junction in the skin (Eidsmo et al., 2009).
Moreover, the epidermal basement membrane represents an impor-
tant barrier protecting underlying dermal tissues from HSV-1
infection (Weeks et al., 2000). Neutrophils are the major cell type
recruited following corneal or skin scariﬁcation of mice with HSV-1
(Chen et al., 1996; Stumpf et al., 2002; Thomas et al., 1997; Watanabe
et al., 1999) and are prominent in epidermal and dermal layers of
human herpetic lesions (Patel et al., 2009). Herein, we demonstrate
that early production of neutrophil-attracting chemokines KC/MIP-2
is associated with transient recruitment of neutrophils into the skin of
HSV-1-infected mice in temporal association with the development of
herpetic lesions. Treatment of HSV-1-infected mice with a Ly6G-
speciﬁc mAb induced systemic neutropenia, but surprisingly did not
alter virus replication or lesion development. In contrast, depletion of
Gr-1+ cells with mAb RB6-8C5 led to enhanced virus growth and
lesion severity. Thus, while neutrophils are prominent in zosteriform
lesions of HSV-1-infectedmice, they do not appear to play amajor role
in controlling virus replication or lesion development and/or healing.
In contrast, Gr-1+ cells limit both virus replication and lesion
development in the zosteriform model.
The human neutrophil chemoattractant interleukin (IL)-8 is a
member of the CXC chemokine family. While there is no murine IL-8,
KC and MIP-2 are considered to be functional homologs in mice
(McColl and Clark-Lewis, 1999). Intracorneal HSV-1 infection is
characterized by the rapid production of MIP-2 and KC by corneal
epithelial cells (Su et al., 1996; Yan et al., 1998), and MIP-2 appears to
be the dominant chemoattractant involved in recruitment of
neutrophils into the infected cornea (Yan et al., 1998). Furthermore,
neutralizing antibodies to MIP-2, but not KC, suppressed delayed-type
hypersensitivity and reduced neutrophil accumulation following virus
challenge of mice sensitized to HSV-1 (Tumpey et al., 2002). Previous
studies have demonstrated production of dermal KC and MIP-2 in
response to surgical injury (Armstrong et al., 2004; Fitzgerald et al.,
2007), but only KC was induced after thermal injury (Faunce et al.,
2003), leading the authors to propose that KC is largely associated
with neutrophil trafﬁcking into the skin. Herein, we demonstrate that
both KC and MIP-2 are induced following ﬂank infection with HSV-1
(Fig. 2C). Many cell types, including epithelial cells, endothelial cells
and monocytes/macrophages have been shown to express one or
both of these chemokines in vitro (Armstrong et al., 2004; Ohmori and
Hamilton, 1994; Rovai et al., 1998; Tumpey et al., 2002). Future
studies will aim to identify the particular cell types producing KC and
MIP-2 in HSV-1-infected skin. Since KC and MIP-2 genes are inducible
in response to a variety of inﬂammatory stimuli (Armstrong et al.,
2004; Ohmori and Hamilton, 1994; Rovai et al., 1998), they may be
secreted from both uninfected and virus-infected cells in HSV-1-
induced zosteriform lesions.
The transient production of neutrophil-attracting chemokines and
accumulation of neutrophils has been demonstrated in a variety ofdermatologic disorders including allergic contact dermatitis, thermal
injury and in experimental animal models of dermal inﬂammation
(Abe et al., 1996; Faunce et al., 1999; Gillitzer et al., 1991; Kondo et al.,
1996). While neutrophils were a prominent component of the
leukocyte inﬁltrate recovered from HSV-1-infected skin (Fig. 2A),
we were surprised to ﬁnd that depletion of neutrophils with mAb 1A8
was not associated with enhanced virus replication (Fig. 4a) and/or
alteration in the development of lesions (Fig. 4C). Despite consider-
able interest in how inﬂammatory cells contribute to immune-
mediated tissue damage and wound healing, little is known about
how neutrophils modulate these processes in the skin. Depletion of
macrophages, but not neutrophils, from guinea pigs was shown to
signiﬁcantly delay the healing process in a wound model (Leibovich
and Ross, 1975; Simpson and Ross, 1972) and epidermal healing,
measured by wound closure, proceeded more rapidly in neutropenic
than control mice (Dovi et al., 2003), suggesting that neutrophils do
not necessarily contribute to wound resolution and, in some cases,
may actually inhibit the repair processes.
If neutrophils play little role in controlling HSV-1 replication in
the skin, why are such high numbers recruited following epidermal
infection? In the murine wound-healing model, a massive neutro-
phil inﬂux is recorded soon after tissue injury, yet depletion of
neutrophils was associated with accelerated epithelial closure
without altering the quality of dermal healing (Dovi et al., 2003).
These ﬁndings led the authors to propose that neutrophil
inﬁltration into wounded tissues is likely to be a non-speciﬁc
innate defence mechanism to protect against microbial infection of
damaged skin. Moreover, it has been proposed that epithelial cells
(including keratinocytes) and neutrophils may cooperate to pro-
mote wound healing with concomitant antimicrobial defence
(Borregaard et al., 2005).
The immunopathological processes underlying the development
and severity of zosteriform lesions are not well understood, although
leukocyte accumulation (Fig. 2A) and expression of pro-inﬂammatory
cytokines have been associated with the development of herpetic skin
lesions (Eidsmo et al., 2009). Depletion of Gr-1+ cells is associated
with a striking increase in levels of MCP-1 in skin homogenates from
HSV-1-infected mice (Fig. 5). MCP-1, a member of the β-chemokine
subfamily, acts as a chemoattractant for a range of immune cells,
mainlymonocyte/macrophage and activated T cells, in pathological as
well as physiological conditions (Carr et al., 1994; Van Riper et al.,
1993). In a mouse model of herpes simplex keratitis, mice lacking
MCP-1 developed more severe ocular lesions (Kim et al., 2006),
however subsequent studies have implicated MCP-1 in mediating
corneal inﬁltration of CD4+ T cells and subsequent tissue destruction
(Lee et al., 2008). MCP-1 has also been shown to increase disease
severity in a mouse model of HSV-2-induced encephalomyelitis by
stimulating Th2 responses (Nakajima et al., 2001). MCP-1 is produced
by a wide range of cells in the skin, including macrophages, endo-
thelial cells, ﬁbroblasts and keratinocytes, in response to a variety of
inﬂammatory stimuli (Gibran et al., 1997). Moreover, MCP-1 plays a
critical role in mediating macrophage/monocyte recruitment into the
skin to facilitate wound healing (DiPietro et al., 1995; Low et al., 2001)
as well as a range of inﬂammatory/ﬁbrotic conditions (reviewed in
(Conti and DiGioacchino, 2001)). Compared to IgG- or 1A8-treated
mice infected with HSV-1, a striking increase was observed in levels of
MCP-1 in the skin of Gr-1+-depleted mice at day 7 post-infection
(Fig. 5). After day 7, lesion severity was diminished in IgG- or 1A8-
treated animals and enhanced in RB6-8C5-treated mice, suggesting a
role for MCP-1 in promoting lesion severity. The precise role of MCP-1
in the development and/or healing of zosteriform lesions will require
further investigation.
The mechanisms underlying exacerbated lesion development in
RB6-treated mice are yet to be determined. At day 7 post-infection,
virus titres in skin were approximately 100-fold higher (Fig. 4B),
levels of MCP-1 were markedly elevated (Fig. 6) and there was a
Fig. 6. Treatment of HSV-1-infected mice with mAb RB6-8C5 is associated with enhanced levels of MCP-1 in the skin. Groups of 5 B6 mice were depleted of neutrophils via i.p.
administration of puriﬁed mAb 1A8 (′1A8′) or mAb RB6-8C5 (′RB6′) 24 h prior to ﬂank infection with 106 PFU of HSV-1 and every second day thereafter. Control groups received an
equivalent concentration of rat IgG (′IgG′). Mice were euthanized at various time points following infection and cytokine and chemokine levels were determined in clariﬁed skin
homogenates. Results are expressed as pg/mg of tissue and bars represent the mean concentration of each chemokine±1 SD. The detection limit for each mediator is indicated by a
dotted line. *levels of chemokine that were signiﬁcantly greater than levels detected in skin from uninfected animals or HSV-1-infected animals treated with either IgG or mAb 1A8
(pb0.05, one-way ANOVA).
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treated animals, although the latter was not signiﬁcantly different to
IgG-treated control animals (Fig. 5). It is interesting to note that the
most marked differences in lesion severity were observed 9–11 days
post-infection, yet virus had been cleared from the skin of all HSV-1-
infected mice, including RB6-treated animals, by day 10 post-
infection. Together, these ﬁndings suggest that direct virus-induced
damage is not the major factor contributing to the persistent
immunopathology in mice depleted of Gr-1+ cells. Cutaneous
wound healing is a highly regulated and complex process that
involves inﬂammation, proliferation and tissue remodelling. The
balance between pro-inﬂammatory and anti-inﬂammatory mediators
is critical and cytokines/chemokines, reactive oxygen species and
growth factors have all been implicated in persistent skin inﬂamma-
tion (reviewed by (Schreml et al.)). Future studies will examine cells
and soluble factors in HSV-1-infected skin 9–11 days post-infection,
with a focus on mediators implicated in delayed wound healing in
other murine models of skin injury and inﬂammation.
Neutrophils were prominent in the skin following ﬂank scariﬁca-
tion with HSV-1 strain KOS, yet neutrophils were only a minor
component of cells inﬁltrating the DRG, despite acute virus replication
(Fig. 1A). Clearly major differences exist in the leukocyte populations
recruited to the skin and sensory neurons in this model. Neutrophils
contribute to inﬂammatory injury in rodent models of neuronal injury
(Ryu et al., 2007; Taoka et al., 1997; Yamasaki et al., 1997) and
metalloproteinases, reactive oxygen species and TNF-α have been
implicated in the neurotoxicity of activated neutrophils for DRG cells
(Nguyen et al., 2007; Shaw et al., 2008). Although neutrophils are
present within membranous sheaths of the ganglion they rarely
inﬁltrate DRG (McLachlan et al., 2007; Morin et al., 2007), suggesting
that regulatory mechanisms may also limit inﬁltration into DRG
during acute HSV-1 infection. Instead, other inﬂammatory cell
populations, including CD8+ T cells, have been implicated in
eliminating lytic virus from DRG during HSV-1 infection (Simmons
et al., 1992; van Lint et al., 2004). Indeed, primary cultures of TG cells
obtained from mice latently infected with HSV-1 produced IL-6, but
not MIP-2, consistent with the lack of neutrophils in neuronal tissues
(Carr et al., 1998). Together, these observations suggest that
neutrophils play little role in modulating HSV-1 infection in the
peripheral nervous system.
Enhanced susceptibility and dysregulated immunity to microbial
pathogens has been widely reported following elimination of Gr-1+
cells with mAb RB6-8C5 (reviewed by (Egan et al., 2008)). A critical
ﬁnding from our study was the demonstration that mAb 1A8 bound
selectively to Ly6Ghigh neutrophils, but not to other leukocyte
populations. In contrast, mAb RB6-8C5 bound strongly to CD8+ T
cells and pDC from naïve mice (Fig. 3A) and Gr-1 expression was
markedly upregulated on F4/80+ splenic macrophages and cDC from
HSV-1-infected animals (Fig. 3B). In a mouse model of inﬂuenza virusinfection, binding of mAb RB6-8C5 correlatedwith expression of Ly6C,
rather than Ly6G (Tate et al., 2009) and the enhanced expression
observed in HSV-1-infected mice would be consistent with the well-
documentedmodulation of Ly6C by inﬂammatory cytokines including
IFN-α or IFN-γ (Jutila et al., 1988; Yamanouchi et al., 1998). These
ﬁndings highlight limitations associated with the use of antibody-
mediated depletion of Gr-1+ cells, particularly in the context of acute
or chronic inﬂammatory settings.
In conclusion, we have shown neutrophils to be prominent in
zosteriform lesions from HSV-1-infected mice, however they do not
play a major role in controlling virus replication or lesion develop-
ment and/or healing. In contrast, Gr-1+ cells limit both virus
replication and lesion development in the zosteriform model.
Materials and methods
Mice and viruses
C57BL/6 (B6) mice were bred and housed in speciﬁc pathogen-
free conditions at the Department of Microbiology and Immunology,
University of Melbourne, Australia. Female mice 6–10 weeks of age
were used for ﬂank scariﬁcation studies. All mice were 6–10 weeks
old. The KOS strain of HSV-1 was grown and titrated on Vero cells.
Vero cells were grown inMEMmedium supplemented with 10% heat-
inactivated FCS, 4 mM L-glutamine, 5×10−5 M 2-ME, and antibiotics.
Virus stocks were stored at −70 °C until required.
Infection and treatment of mice
A modiﬁed form of the ﬂank scariﬁcation method described by
Simmons and Nash was used (Simmons and Nash, 1984; van Lint et
al., 2004). Brieﬂy, mice were anaesthetised by intraperitoneal (i.p.)
injection (10μL/g body weight) with a 1:1 ketamine (Parnell
Laboratories, Alexandria, Australia)/Ilium Xylazil-20 (Troy Laborato-
ries, Smithﬁeld, Australia) and the left ﬂank of each mouse was
clipped, depilated and a small area of skin near the top of the spleen
was abraded using a MultiPro power tool (Dremel, Racine, WI) with a
grindstone attachment (3.2 mm). A 10-μL volume of virus containing
106 PFU was applied to the abraded skin as described (van Lint et al.,
2004). All research complied with the University of Melbourne's
Animal Experimentation Ethics guidelines and policies.
At various times after infection, micewere euthanized and the skin
and dorsal root ganglia (DRG) were removed, homogenised in
phosphate-buffered saline (PBS) and clariﬁed by centrifugation. In
all experiments, a skin sample of ~1 cm×2 cm (including inoculation
site and area of subsequent dermatome lesion) was excised for
analysis. Titres of infectious virus in tissue homogenates were
determined by standard plaque assay on Vero cells.
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Photos were taken of each mouse on the indicated days following
infection and scored for lesion severity using the scoring system
detailed below. Score is indicated in brackets following description of
lesion. No sign of vesicles (0), ulcerated local vesicles, erythema and/
or inﬂammation (1), ulcerated vesicles throughout the dermatome
(2), regions of severe ulceration, presence of large lesions (3), severe
ulcerations throughout the entire dermatome (4), continuous
ulceration over entire dermatome (5), appearance of vesicles in
adjacent dermatomes and/or contralateral spread (6).
Neutrophil depletions
For the depletion of neutrophils in vivo, puriﬁed anti-Ly6G rat mAb
(1A8, a gift from Prof. Thomas Malek, Dept. Microbiology and
Immunology, University of Miami, Florida, USA) or mAb RB6-8C5
(anti-Ly6G/Ly6C, also known as anti-Gr-1) were administered to
mice. Control animals received a similar dose of puriﬁed whole rat IgG
(Jackson Laboratories, USA). To deplete neutrophils during ﬂank
infection, mice received an i.p. injection (0.5 mg in 0.2 mL) only. Mice
were treated 24 h prior to infection and every 48 h thereafter.
Differential leukocyte counts (described below) conﬁrmedN95%
depletion of blood neutrophils using these treatment regimes.
Recovery, differential counts and ﬂow cytometry of leukocytes from mice
Skin lesions, DRG, spleen and heparinized blood were obtained as
previously described (van Lint et al., 2004). To determine cellular
inﬁltration into the skin, a sample of ~1 cm×2 cm (including
inoculation site and area of subsequent dermatome lesion) was
excised for analysis.
To obtain single cell suspensions, skin was ﬁnely minced with
scissors. Skin or DRG were then incubated for 30 min at 37°C with
2 mg/mL Collagenase A (Roche Diagnostics, Germany) and passed
through a wire mesh. Whole spleen was sieved through a wire mesh
to obtain single cell suspensions. Skin, DRG and spleen cell suspen-
sions were treated with Tris-NH4Cl (0.14 M NH4Cl in 17 mM Tris,
adjusted to pH 7.2) to lyse erythrocytes and washed in RPMI
1640 medium supplemented with 10% FCS (RF10). Cell numbers
and cell viability were assessed via trypan blue exclusion using a
haemocytometer.
For ﬂow cytometry analysis, single cell suspensions were incubat-
ed on ice for 20 minwith supernatants from hybridoma 2.4G2 to block
Fc receptors and then stained with appropriate combinations of
ﬂuorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocya-
nin (APC) or biotinylated monoclonal antibodies to Ly6G (1A8), Gr-1
(RB6-8C5), Ly6C (AL-21), CD45.2 (104), CD8a (53-6.7), CD4 (GK1.5),
B220 (RA3-6B2), NK1.1 (PK136), CD3e(145-2C11), MHC class II (I-Ab,
AF6-120.1), CD11c (HL3, all from BD PharMingen), F4/80 (BM8,
Caltag Lab.) and mPDCA-1 (JF05-1C2.4.1, Miltenyi Biotec Inc.).
Propidium iodide (PI; 10 μg/ml) was added to each sample prior to
the acquisition of data on a FACS Calibur ﬂow cytometer. A minimum
of 50,000 live cells (PI−) were collected. For analysis, PI− cells were
gated and the percent of each leukocyte population within this gate
was determined. The viable count was then used to determine the cell
numbers of each leukocyte population in skin, blood or DRG.
Leukocyte populations were sorted using a MoFlo cell sorter
(DakoCytomation, Denmark). Note that we have used F4/80 to
identify “macrophage-like” cells as this molecule is expressed widely
on different macrophage populations but is also expressed by other
subpopulations of myeloid cells, including Langerhans cells and CD8-
DC (van den Berg and Kraal, 2005).
To obtain samples for the identiﬁcation of conventional and
plasmacytoid dendritic cells (cDC and pDC, respectively), spleen cell
suspensions were digested for 20 min at room temperature withcollagenase/DNase (1 mg/mL collagenase type II, Worthington
Biochemicals, Lakewood, NJ; and 1 μg/mL grade II bovine pancreatic
DNase I, Boehringer-Mannheim, Mannheim, Germany) as previously
described (Vremec et al., 2000). Samples were then treated for a
further 5 min with EDTA to disrupt T cell-DC complexes. cDCs were
identiﬁed as CD11chigh, MHC Class IIhigh (I-Ab) (Henri et al., 2001) and
pDCs as CD11cint, PDCA-1+ cells (Swiecki and Colonna).
Chemokine and cytokine levels in murine skin homogenates
In some experiments, mice were euthanized and a skin sample of
~1 cm×2 cm (including inoculation site and area of subsequent
dermatome lesion) was excised for analysis. Skin was homogenised in
PBS, clariﬁed by centrifugation and levels of IFN-γ, TNF-α, IL-6/CCL2
and MCP-1/CCL2 were determined by mouse cytokine bead array
(Becton Dickinson, USA) according to manufacturer's instructions.
Inﬂammatory mediator concentrations were calculated from a
standard curve and expressed as pg/mL. Levels of murine KC/CXCL1
andMIP-2/CXCL2 were determined via ELISA (Roche, USA), according
to manufacturer's instructions. The detection limits for KC and MIP-2
were 5 pg/ml.
Statistical analysis
When comparing three or more sets of values, data were analyzed
by one-way ANOVA (nonparametric) followed by post-hoc analysis
using Tukey's multiple comparison test. A p value of ≤0.05 was
considered statistically signiﬁcant.
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